[vc_row][vc_column][bsf-info-box icon=”Defaults-info-circle” icon_size=”32″ title=”Abstract submission is closed.” el_class=”display-hide”][/bsf-info-box][vc_empty_space height=”20px”][vc_column_text]The Emirates Haematology Conference 2023, Scientific Committee invites authors to submit abstracts for poster and workshop abstracts to be presented at the exclusive platform of EHC 2023. It will provide a premier platform for researchers to be able to present their work through poster formats to international colleagues.
Abstracts are submitted online. Abstracts will be reviewed, and accepted submissions will be presented at the conference.[/vc_column_text][vc_btn title=”Submit Abstract” style=”custom” custom_background=”#b6205f” custom_text=”#ffffff” i_icon_fontawesome=”fas fa-microphone” add_icon=”true” link=”url:https%3A%2F%2Fevents.mme-conferences.com%2Fehc2023%2Fcall-for-abstract|target:_blank”][/vc_column][/vc_row][vc_row][vc_column][ultimate_heading main_heading=”Guidelines for submitting an abstract :” main_heading_color=”#26326e” alignment=”left” main_heading_style=”font-weight:bold;” main_heading_font_size=”desktop:20px;”][/ultimate_heading][vc_empty_space height=”20px”][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][info_list style=”circle with_bg” icon_bg_color=”#b6205f” icon_color=”#ffffff” font_size_icon=”24″ eg_br_width=”1″][info_list_item list_title=”18 November 2022″ list_icon=”Defaults-calendar”]Abstract Submissions Open (Poster)[/info_list_item][info_list_item list_title=”10 February 2023″ list_icon=”Defaults-calendar”]Abstracts Submissions Close (Poster)[/info_list_item][info_list_item list_title=”20 February 2023″ list_icon=”Defaults-calendar”]Author Notifications (Poster)[/info_list_item][/info_list][vc_btn title=”View More Dates” style=”custom” custom_background=”#b6205f” custom_text=”#ffffff” shape=”round” size=”sm” i_icon_fontawesome=”fas fa-microphone” add_icon=”true” link=”url:%23|target:_blank”][/vc_column][vc_column width=”1/2″][vc_column_text]

A special criterion for accepting abstracts will be their topic as well as structure, content and degree of innovation.

  • Please note that a maximum of 300 words is permitted. The titles and the names of the authors are excluded from this number and have to be entered separately. Tables should not be included in the abstract body.
  • Methods section should include type of statistical analysis done if applicable to the study.
  • Statements like “Results will be discussed” are not acceptable and may lead to a rejection of the abstract.

The scientific committee will accept abstracts based on their relevance and quality, structure, content and degree of innovation.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_separator style=”shadow” border_width=”2″][ultimate_heading main_heading=”Abstract Topics :” main_heading_color=”#26326e” alignment=”left” main_heading_style=”font-weight:bold;” main_heading_font_size=”desktop:20px;”][/ultimate_heading][vc_empty_space height=”18px”][vc_row_inner][vc_column_inner width=”1/2″]

  • Red Blood Cells and Iron:Physiology and Disease
  • Stem Cell Transplantation
  • Transfusion Medicine
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Bone Marrow Failure
  • Chronic Lymphocytic Leukemia and Related Disorders
  • Chronic Myelogenous Leukemia
  • Coagulation Disorders
  • Cytogenics and Molecular Diagnostics
  • Drug Resistance and Pharmacology
  • Genomics and Proteomics
  • Hemostasis & Thrombosis
  • Hodgkin Lymphoma
  • Infections in the Immune Compromised Host
[/vc_column_inner][vc_column_inner width=”1/2″]
  • Training & Education in Hematology and Hematopathology
  • Iron Overload
  • ITP
  • Lymphoma
  • MDS and Bone Marrow Failure Syndromes including PNH
  • Myeloma
  • Myeloma and other Monoclonal Gammopathies
  • Myeloproliferative Disorders
  • Non Hodgkin Lymphoma
  • Novel Therapeutics, Targeted Therapies and Gene Therapy
  • Pediatric Haematology
  • Platelets and Thrombocytopenia
  • Quality & Patient Safety in Hematology & Hematopathology
  • Quality of Life, Palliative Care and Ethics
  • CAR T Cells
[/vc_column_inner][/vc_row_inner][vc_separator style=”shadow” border_width=”2″][vc_empty_space height=”18px”][vc_row_inner][vc_column_inner width=”1/2″][ultimate_heading main_heading=”Structure of the Abstract for Poster Presentations” main_heading_color=”#26326e” alignment=”left” main_heading_style=”font-weight:bold;” main_heading_font_size=”desktop:20px;”][/ultimate_heading][vc_empty_space height=”18px”]
  • Background and Purpose
  • Methods
  • Results
  • Conclusions
[/vc_column_inner][vc_column_inner width=”1/2″][ultimate_heading main_heading=”Structure of the Abstract for Workshops” main_heading_color=”#26326e” alignment=”left” main_heading_style=”font-weight:bold;” main_heading_font_size=”desktop:20px;”][/ultimate_heading][vc_empty_space height=”18px”]
  • Authors
  • Workshop Title
  • Background
  • Aim
  • Session Description/Methodology
  • Estimated number of attendees
  • Keywords
  • Conclusion
  • Special request
[/vc_column_inner][/vc_row_inner][vc_separator style=”shadow” border_width=”2″][/vc_column][/vc_row][vc_row][vc_column][ultimate_heading main_heading=”Abstract Delivery Notification” main_heading_color=”#26326e” alignment=”left” main_heading_style=”font-weight:bold;” main_heading_font_size=”desktop:20px;”][/ultimate_heading][vc_empty_space height=”18px”][vc_column_text]Authors will be notified about the delivery of their abstract by e-mail immediately. In case you do not receive confirmation within 24 hours, please check your spam folder. In case of no confirmation e-mail, please contact: ehc@meetingmindsexperts.com[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][ultimate_heading main_heading=”Author Agreement :” main_heading_color=”#26326e” alignment=”left” main_heading_style=”font-weight:bold;” main_heading_font_size=”desktop:20px;”][/ultimate_heading][vc_empty_space height=”18px”][vc_column_text]By submitting the abstract, the author confirms and agrees to the following:

  1. All authors approve submitting this work for presentation.
  2. The authors have done the work reported in the abstract and take full responsibility for the contents.
  3. The authors transfer all copyright ownership of the abstract to the EHC 2023.
  4. The authors agree to confine their presentation to information in the abstract.
  5. At least one author will be available to present the abstract if selected for the program.
  6. The author will immediately notify the EHC 2023 Scientific Committee if they are unable to make a presentation or if the presenting author must be changed.
  7. The authors guarantee that clinical studies and any animal tests have proceeded with the official permission from the proper authorities.
  8. All presenters will be responsible for their own registration fees, hotel and travel expenses. We regret that we cannot waive registration fees or cover expenses for any poster presenters.